Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.

Clinical trial NCT02659033 · COMPLETED

Trial details

NCT number: NCT02659033
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Emergence of Bacterial Resistance to Antibiotics

Start date: 2016-03-01
Primary completion: 2016-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.